These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 3548307

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise.
    Bayliss J, Canepa-Anson R, Norell MS, Poole-Wilson P, Sutton G.
    Br Heart J; 1986 Mar; 55(3):265-73. PubMed ID: 3513808
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.
    Bayliss J, Norell MS, Canepa-Anson R, Reid C, Poole-Wilson P, Sutton G.
    Br Med J (Clin Res Ed); 1985 Jun 22; 290(6485):1861-5. PubMed ID: 3924285
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The renal response to neuroendocrine inhibition in chronic heart failure: double-blind comparison of captopril and prazosin.
    Bayliss J, Canepa-Anson R, Norell M, Poole-Wilson P, Sutton G.
    Eur Heart J; 1986 Oct 22; 7(10):877-84. PubMed ID: 3539615
    [Abstract] [Full Text] [Related]

  • 9. Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: importance of initial plasma renin activity.
    Mettauer B, Rouleau JL, Bichet D, Kortas C, Manzini C, Tremblay G, Chatterjee K.
    Circulation; 1986 Mar 22; 73(3):492-502. PubMed ID: 3512121
    [Abstract] [Full Text] [Related]

  • 10. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
    Silberbauer K, Punzengruber C, Sinzinger H.
    Cardiology; 1983 Mar 22; 70(6):297-307. PubMed ID: 6370431
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Angiotensin converting enzyme inhibitors in congestive heart failure. Overview in comparison of captopril and enalapril.
    Levine TB, Olivari MT, Cohn JN.
    Am J Med; 1986 Oct 31; 81(4C):36-9. PubMed ID: 3022583
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Use of captopril to estimate renin-angiotensin-aldosterone activity in the pathophysiology of chronic heart failure.
    Cody RJ, Laragh JH.
    Am Heart J; 1982 Nov 31; 104(5 Pt 2):1184-9. PubMed ID: 6291364
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Captopril does not prevent nitroglycerin tolerance in heart failure.
    Dupuis J, Lalonde G, Bichet D, Rouleau JL.
    Can J Cardiol; 1990 Sep 31; 6(7):281-6. PubMed ID: 2121325
    [Abstract] [Full Text] [Related]

  • 20. Na+, K+, and BP homeostasis in man during furosemide: effects of prazosin and captopril.
    Wilcox CS, Guzman NJ, Mitch WE, Kelly RA, Maroni BJ, Souney PF, Rayment CM, Braun L, Colucci R, Loon NR.
    Kidney Int; 1987 Jan 31; 31(1):135-41. PubMed ID: 3550214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.